Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs4801803 | chr19:37966923 | A/G | 1.37E-13 | 134 | 17.1 | 37.53 | 45.47 | KM Plot |
| TGCT | rs4802236 | chr19:37919246 | A/G | 2.27E-13 | 132 | 45.83 | 36.12 | 17.1 | KM Plot |
| TGCT | rs4802766 | chr19:37981933 | T/C | 1.78E-13 | 133 | 46.3 | 35.03 | 17.1 | KM Plot |
| TGCT | rs4802889 | chr19:37990104 | G/A | 1.78E-13 | 133 | 46.3 | 35.03 | 17.1 | KM Plot |
| TGCT | rs4806021 | chr19:34970086 | T/C | 3.97E-5 | 132 | 43.03 | 46.77 | 40.57 | KM Plot |
| TGCT | rs482731 | chr13:21846075 | G/A | 5.93E-7 | 132 | 46.3 | 36.7 | 14.42 | KM Plot |
| TGCT | rs483893 | chr17:39340826 | T/C | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs483929 | chr17:39340812 | T/C | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs4839913 | chr6:98019234 | C/G | 8.92E-5 | 132 | 37.75 | 60.73 | 1.4 | KM Plot |
| TGCT | rs484365 | chr13:21845944 | G/T | 5.93E-7 | 132 | 46.3 | 36.7 | 14.42 | KM Plot |
| TGCT | rs4851196 | chr2:99858556 | A/G | 0.000111 | 134 | 30.55 | 56.7 | 42.27 | KM Plot |
| TGCT | rs485361 | chr13:21845826 | G/T | 5.93E-7 | 132 | 46.3 | 36.7 | 14.42 | KM Plot |
| TGCT | rs4871341 | chr8:124078080 | C/G | 6.29E-5 | 133 | 37.3 | 49.93 | 56.7 | KM Plot |
| TGCT | rs487167 | chr3:172421624 | T/G | 1.66E-5 | 132 | 45.47 | 37.42 | 24.15 | KM Plot |
| TGCT | rs4885478 | chr13:78233793 | T/C | 1.1E-5 | 132 | 15.7 | 35.37 | 42.18 | KM Plot |